Allworth Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.23M | Sell |
4,487
-11,316
| -72% | -$5.02M | 0.01% | 504 |
|
|
2026
Q1 | $7.06M | Buy |
15,803
+1,767
| +13% | +$824K | 0.03% | 306 |
|
|
2025
Q4 | $6.36M | Buy |
14,036
+11,306
| +414% | +$4.87M | 0.03% | 312 |
|
|
2025
Q3 | $1.07M | Sell |
2,730
-732
| -21% | -$306K | ﹤0.01% | 650 |
|
|
2025
Q2 | $1.54M | Buy |
3,462
+1,516
| +78% | +$699K | 0.01% | 540 |
|
|
2025
Q1 | $958K | Buy |
1,946
+205
| +12% | +$95.5K | 0.01% | 530 |
|
|
2024
Q4 | $745K | Buy |
1,741
+92
| +6% | +$42.6K | ﹤0.01% | 599 |
|
|
2024
Q3 | $767K | Sell |
1,649
-114
| -6% | -$54.8K | ﹤0.01% | 486 |
|
|
2024
Q2 | $867K | Buy |
1,763
+565
| +47% | +$245K | 0.01% | 448 |
|
|
2024
Q1 | $501K | Buy |
1,198
+55
| +5% | +$23.3K | ﹤0.01% | 548 |
|
|
2023
Q4 | $465K | Buy |
1,143
+59
| +5% | +$21.8K | ﹤0.01% | 535 |
|
|
2023
Q3 | $377K | Buy |
1,084
+173
| +19% | +$60.5K | ﹤0.01% | 546 |
|
|
2023
Q2 | $321K | Sell |
911
-4
| -0.4% | -$1.35K | ﹤0.01% | 594 |
|
|
2023
Q1 | $288K | Buy |
915
+105
| +13% | +$31.5K | ﹤0.01% | 571 |
|
|
2022
Q4 | $234K | Buy |
810
+115
| +17% | +$35K | ﹤0.01% | 600 |
|
|
2022
Q3 | $201K | Buy |
695
+52
| +8% | +$15K | ﹤0.01% | 592 |
|
|
2022
Q2 | $181K | Buy |
643
+97
| +18% | +$26K | ﹤0.01% | 578 |
|
|
2022
Q1 | $142K | Buy |
546
+11
| +2% | +$2.61K | ﹤0.01% | 634 |
|
|
2021
Q4 | $117K | Buy |
535
+505
| +1,683% | +$98.2K | ﹤0.01% | 648 |
|
|
2021
Q3 | $5K | Buy |
30
+4
| +15% | +$781 | ﹤0.01% | 1542 |
|
|
2021
Q2 | $5K | Hold |
26
| – | – | ﹤0.01% | 1229 |
|
|
2021
Q1 | $6K | Sell |
26
-100
| -79% | -$22K | ﹤0.01% | 1112 |
|
|
2020
Q4 | $30K | Buy |
126
+100
| +385% | +$22.9K | ﹤0.01% | 577 |
|
|
2020
Q3 | $7K | Hold |
26
| – | – | ﹤0.01% | 791 |
|
|
2020
Q2 | $8K | Hold |
26
| – | – | ﹤0.01% | 785 |
|
|
2020
Q1 | $6K | Hold |
26
| – | – | ﹤0.01% | 844 |
|
|
2019
Q4 | $6K | Hold |
26
| – | – | ﹤0.01% | 747 |
|
|
2019
Q3 | $4K | Hold |
26
| – | – | ﹤0.01% | 732 |
|
|
2019
Q2 | $5K | Hold |
26
| – | – | ﹤0.01% | 688 |
|
|
2019
Q1 | $5K | Hold |
26
| – | – | ﹤0.01% | 694 |
|
|
2018
Q4 | $4K | Hold |
26
| – | – | ﹤0.01% | 661 |
|
|
2018
Q3 | $5K | Hold |
26
| – | – | ﹤0.01% | 667 |
|
|
2018
Q2 | $4K | Sell |
26
-1
| -4% | -$155 | ﹤0.01% | 692 |
|
|
2018
Q1 | $4K | Sell |
27
-1
| -4% | -$163 | ﹤0.01% | 630 |
|
|
2017
Q4 | $4K | Buy |
28
+2
| +8% | +$296 | ﹤0.01% | 603 |
|
|
2017
Q3 | $4K | Hold |
26
| – | – | ﹤0.01% | 606 |
|
|
2017
Q2 | $3K | Hold |
26
| – | – | ﹤0.01% | 647 |
|
|
2017
Q1 | $3K | Hold |
26
| – | – | ﹤0.01% | 618 |
|
|
2016
Q4 | $2K | Hold |
26
| – | – | ﹤0.01% | 599 |
|
|
2016
Q3 | $2K | Hold |
26
| – | – | ﹤0.01% | 604 |
|
|
2016
Q2 | $2K | Hold |
26
| – | – | ﹤0.01% | 562 |
|
|
2016
Q1 | $2K | Hold |
26
| – | – | ﹤0.01% | 541 |
|
|
2015
Q4 | $3K | Hold |
26
| – | – | ﹤0.01% | 514 |
|
|
2015
Q3 | $3K | Hold |
26
| – | – | ﹤0.01% | 510 |
|
|
2015
Q2 | $3K | Hold |
26
| – | – | ﹤0.01% | 503 |
|
|
2015
Q1 | $3K | Buy |
+26
| New | +$3.12K | ﹤0.01% | 507 |
|
Other funds holding VRTX
Allworth Financial's VRTX Position: Q2 2026 in Review
Allworth Financial reduced its Vertex Pharmaceuticals (VRTX) stake by 72% in Q2 2026, selling an estimated $5.02M and leaving 4,487 shares worth $2.23M. The position accounts for 0.01% of the portfolio, ranked #504.
Allworth Financial first reported a position in VRTX in Q1 2015 and has held it in 46 quarters since. The position peaked at $7.06M in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Allworth Financial held 4,487 shares of Vertex Pharmaceuticals worth $2.23M as of Q2 2026.
- Allworth Financial sold 11,316 Vertex Pharmaceuticals shares in Q2 2026, an estimated $5.02M.
- Vertex Pharmaceuticals made up 0.01% of Allworth Financial's portfolio in Q2 2026, its #504 holding.
- Allworth Financial first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 46 quarters since.
- Allworth Financial's Vertex Pharmaceuticals position peaked at $7.06M in Q1 2026.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.